Literature DB >> 15139489

Celiac disease and lymphoma risk: a multicentric case--control study in Spain.

Carme Farré1, Eva Domingo-Domenech, Rebeca Font, Teresa Marques, Alberto Fernandez de Sevilla, Tomas Alvaro, Mercedes Garcia Villanueva, Vicens Romagosa, Silvia de Sanjose.   

Abstract

Celiac disease is a highly prevalent condition frequently misdiagnosed because of heterogeneity of the clinical symptoms. It is well recognized that enteropathy-associated T-cell lymphoma is an uncommon lymphoma type linked to celiac disease; it has also been suggested that other types of lymphomas may be associated with celiac disease. Our aim was to estimate the risk of all lymphoma associated with celiac disease. Serological markers and personal interviews were obtained from 298 consecutive lymphoma cases and 251 matched controls recruited in four Spanish hospitals. Celiac disease was detected in two cases (0.67%; n = 298) and in three controls (1.2%; n = 251). Treated celiac disease was observed in one patient with lymphoma and in two control subjects. In our series, there was no evidence that celiac disease was a risk factor for lymphoma (OR = 0.62, 95% CI = 0.10-3.79). Serological screening for CD is not recommended in people with lymphoma.

Entities:  

Mesh:

Year:  2004        PMID: 15139489     DOI: 10.1023/b:ddas.0000020494.79480.30

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Tissue sources and blood flow limitations of osmotic water transport across the peritoneum.

Authors:  H Demissachew; J Lofthouse; M F Flessner
Journal:  J Am Soc Nephrol       Date:  1999-02       Impact factor: 10.121

2.  Paradoxes in peritoneal transport of small solutes.

Authors:  J Waniewski; O Heimbürger; A Werynski; B Lindholm
Journal:  Perit Dial Int       Date:  1996       Impact factor: 1.756

3.  Diffusive mass transport coefficients are not constant during a single exchange in continuous ambulatory peritoneal dialysis.

Authors:  J Waniewski; O Heimbürger; A Werynski; B Lindholm
Journal:  ASAIO J       Date:  1996 Sep-Oct       Impact factor: 2.872

4.  The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.

Authors:  C E Douma; D R de Waart; D G Struijk; R T Krediet
Journal:  Kidney Int       Date:  1997-06       Impact factor: 10.612

5.  Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.

Authors:  Claus P Schmitt; Börje Haraldsson; Rouven Doetschmann; Mirjam Zimmering; Christine Greiner; Michael Böswald; Günter Klaus; Jutta Passlick-Deetjen; Franz Schaefer
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

6.  Fluid and solute transport in CAPD patients using ultralow sodium dialysate.

Authors:  A L Imholz; G C Koomen; D G Struijk; L Arisz; R T Krediet
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

7.  Dynamic changes of the total pore area available for peritoneal exchange in children.

Authors:  Michel Fischbach; Börje Haraldsson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

8.  Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions.

Authors:  El Rasheid Zakaria; David A Spain; Patrick D Harris; R Neal Garrison
Journal:  Perit Dial Int       Date:  2002 Sep-Oct       Impact factor: 1.756

9.  Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes.

Authors:  T M Chang
Journal:  Artif Organs       Date:  1992-02       Impact factor: 3.094

10.  Nitrate in stable CAPD patients and during peritonitis.

Authors:  C E Douma; D R de Waart; D Zemel; A L Imholz; G C Koomen; D G Struijk; R T Krediet
Journal:  Adv Perit Dial       Date:  1995
View more
  8 in total

1.  Screening for celiac disease in average-risk and high-risk populations.

Authors:  Saurabh Aggarwal; Benjamin Lebwohl; Peter H R Green
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Natural antibiotic expression in celiac disease--correlation with villous atrophy and response to a gluten-free diet.

Authors:  Ali S Taha; Elena Faccenda; Wilson J Angerson; Margaret Balsitis; Rodney W Kelly
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

3.  A rare case of enteropathy-associated T-cell lymphoma presenting as acute renal failure.

Authors:  Milena Bakrac; Branka Bonaci; Miodrag Krstic; Sanja Simic; Milica Colovic
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

4.  Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association.

Authors:  Ying Gao; Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

5.  Clinical utility of serologic testing for celiac disease in asymptomatic patients: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-07-01

6.  Diagnosing celiac disease in patients with a history of lymphoma: factors that matter.

Authors:  Karel Balihar; Jana Kozeluhova; Vaclav Hejda; Michal Krcma; Daniel Lysak; Jitka Gorcikova; Ondrej Hes; Martin Matejovic
Journal:  Wien Klin Wochenschr       Date:  2013-10-23       Impact factor: 1.704

7.  Mortality in coeliac disease: a population-based cohort study from a single centre in Southern Derbyshire, UK.

Authors:  Geoffrey K T Holmes; Andrew Muirhead
Journal:  BMJ Open Gastroenterol       Date:  2018-04-17

Review 8.  Geographic trends and risk of gastrointestinal cancer among patients with celiac disease in Europe and Asian-Pacific region.

Authors:  Mohammad Rostami Nejad; David Aldulaimi; Sauid Ishaq; Mohammad Javad Ehsani-Ardakani; Mohammad Reza Zali; Reza Malekzadeh; Kamran Rostami
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.